Ikarian Capital’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$687K Sell
2022
Q1
$2.34M Sell
2021
Q4
$6.55M Buy